Skip to content

Drug interactions

Lenacapavir + Metformin-repaglinide

Severity: Moderate

Lenacapavir and Metformin-repaglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor and may increase repaglinide exposure. This could raise the risk of hypoglycemia. Repaglinide is also cleared via CYP2C8, which moderates the effect.

What this interaction means in plain words

Lenacapavir and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Metformin-repaglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Moderate CYP3A4 inhibition reduces repaglinide metabolism.

What to do

Monitor blood glucose when lenacapavir is started and reduce the repaglinide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Metformin-repaglinide?

MediHelp rates the interaction as moderate. Lenacapavir and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor and may increase repaglinide exposure. This could raise the risk of hypoglycemia. Repaglinide is also cleared via CYP2C8, which moderates the effect.

How serious is the interaction between Lenacapavir and Metformin-repaglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when lenacapavir is started and reduce the repaglinide dose if hypoglycemia occurs.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in